Summary
Serum C-peptide, insulin-binding IgG and total insulin (IRI) were determined in 96 juvenile diabetics aged 4–21 years, with onset of diabetes at the age of 1–16 years and with 2–17 years' duration of diabetes. Thirty-four patients (35.4%) had detectable levels of C-peptide (≥ 0.04 pmol/ml). Compared to non-diabetic adults, 19 had values below the normal range, 12 showed values within the normal range (0.18–0.63 pmol/ml) and 3 rated above normal. There was a negative correlation between the fasting C-peptide concentration and the degree of ketonuria at the onset of diabetes and a positive correlation between C-peptide levels and the incidence of postinitial remission periods. Patients without detectable C-peptide had significantly higher levels of insulin antibodies than those who had detectable levels of C-peptide. The possibility of a relationship between the intensity of the initial treatment of diabetes and the preservation of the B-cell function is discussed, as well as the possibility of insulin antibodies being a cause of B-cell exhaustion.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Beischer, W., Raptis, S., Keller, L., Heinze, E., Schröder, K. E., Pfeiffer, E. F.: Characterization of the residual beta-cell function in diabetics by a new C-peptide radioimmunoassay. Diabetologia11, 332 (1975)
Block, M. B., Mako, M. E., Steiner, D. F., Rubenstein, A. H.: Circulating C-peptide immunoreactivity. Diabetes21, 1013–1026 (1972)
Christiansen, A. H.: Radioimmunoelectrophoresis in the determination of insulin binding to IgG. Methodological studies. Horm. Metab. Res.5, 147–154 (1973)
Drash, A.: Chemical diabetes mellitus in the child. Metabolism22, 255 (1973)
Ehrlich, R. M.: Diabetes mellitus in childhood. Pediat. Clin. N. Amer.21, 871–884 (1974)
Elliot, R. B., O'Brien, D., Roy, C. C.: An abnormal insulin in juvenile diabetes mellitus. Diabetes14, 780–787 (1965)
Faber, O. K., Binder, C., Lauritzen, T., Heding, L. G.: Preserved beta-cell function and blood glucose control in insulin dependent diabetes mellitus. Abstract for Annual Meetings Program, American Diabetes Association 1976
Faber, O. K., Markussen, J., Naithani, V. K., Binder, C.: High titer and — sensitivity antisera to the synthetic benzyloxycarbonyl — C-peptide of human proinsulin. Hoppe-Seylers Z. physiol. Chem. (Acc. for publ. 1976)
Fink, G., Cresto, J. C., Gutman, R. A., Lavine, R. L., Rubenstein, A. H., Recant, L.: Plasma proinsulin-like material in insulin treated diabetics. Horm. Metab. Res.6, 439–443 (1974)
Heding, L. G.: Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia8, 260–266 (1972)
Heding, L. G.: Radioimmunological determination of human C-peptide in serum. Diabetologia11, 541–548 (1975)
Heding, L. G., Munkgaard-Rasmussen, S.: Human C-peptide in normal and diabetic subjects. Diabetologia11, 201–206 (1975)
Horwitz, D. L., Starr, J. I., Mako, M. E., Blackard, W. C., Rubenstein, A. H.: Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J. clin. Invest.55, 1278–1283 (1975)
Ludvigsson, J., Heding, L. G.: C-peptide in diabetic and non diabetic children. Response to glucagon. (To be published)
Marble, A., White, P., Bradley, R. F., Krall, L. P., (eds): Joslin's diabetes mellitus. 11 ed. Philadelphia: Lea & Febiger 1971
Morgan, C. R., Carpenter, A.-M., Lazarow, A.: Effect of insulin antibodies on pancreatic islet insulin and beta cell granule content. Anat. Rec.153, 49–54 (1965)
Porte, D., Bagdade, J.: Human insulin secretion: an integrated approach. Ann. Rev. Med.21, 219–240 (1970)
Toreson, W. E., Lee, J. C., Grodsky, G. M.: The histopathology of immune diabetes in the rabbit. Amer. J. Path.52, 1099–1109 (1968)
Unger, R. H., Orci, L.: The essential role of glucagon in the pathogenesis of diabetes mellitus. Lancet 1975I, 14–16
Wright, W. R., Rainwater, J. C., Tolle, L.: Glucose assay systems. Evaluation of a colorimetric hexokinase procedure. Clin. Chem.17, 1010–1015 (1971)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ludvigsson, J., Heding, L.G. C-Peptide in children with juvenile diabetes. Diabetologia 12, 627–630 (1976). https://doi.org/10.1007/BF01220642
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01220642